Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Adicionar filtros








Intervalo de ano
1.
Rev. méd. Chile ; 125(4): 409-18, abr. 1997. tab, ilus
Artigo em Espanhol | LILACS | ID: lil-196284

RESUMO

Patients and methods: Five hundred eighty nine patients whose main symptom was the presence of mucocutaneous hemorrhages were studied. Bleeding time, platelet count, coagulant activity of factor VIII (FVIII:C), FvW: Ag and FvW:CoRis and ABO blood group were measured in all patients in a first stage. According to the results of these tests, further studies were decided. Results: In patients younger than 13 years old, males predominated and, in older patients, females consulted with higher frequency. There was a higher proportion of individuals with O blood type than in the normal population. Bleeding time was abnormal in 330 patients (56 percent). One hundred ten patients (19 percent) had von Willebrand disease and, among them, one third had a normal bleeding time. Isolated reduction of factor VIII activity was found in 66 patients (11 percent, 51 males) and 32 of these had normal bleeding time. Eighty one patients (14 percent) were considered to have an hereditary platelet function defect. A precise diagnosis was not achieved in 332 patients (56 percent). Conclusions: Among patients consulting for mucocutaneous hemorrhages, 19 percent had von Willebrand disease, 11 had an isolated reduction of factor VIII activity, 14 percent had platelet function defects and in 56 percent, a precise diagnosis was not reached


Assuntos
Humanos , Masculino , Feminino , Adolescente , Adulto , Transtornos Hemorrágicos/epidemiologia , Mucosa/fisiopatologia , Doenças de von Willebrand/epidemiologia , Fator de von Willebrand/isolamento & purificação
2.
Medicina (B.Aires) ; 57(4): 409-16, 1997. tab, ilus
Artigo em Inglês | LILACS | ID: lil-209873

RESUMO

The perfusion of serum, citrated whole blood and citrated plasma, through a simple tube system resulted in a significant loss of large von Willebrand factor (vWf) multimers, without decrease in antigen levels. Maximum loss of large multimers was observed at a shear rate of 15,000 s(-1) for 15 min. Heparin, aprotinin, soybean trypsin inhibitor, phenylmethylsulphonylfluoride, N-ethylmaleimide, leupeptin or calpain inhibitor peptide could not prevent the loss of large vWf multimers in citrated plasma. The addition of EDTA calcium salt partially prevented it, and it was totally prevented by EDTA without calcium. Perfusion of purified vWf did not induce the loss of large multimers, but this did happen after the addition of either whole serum or a plasma fraction. The activity of this plasma fraction disappeared at pH < 6.8. Besides, we have found that the binding to subendothelium of purified vWf diluted in dialized serum was lower at pH 7.2 than at pH 6.0. Chromatographic studies demonstrated that the loss of large vWf multimers, induced by high shear rates, involves a plasma substance(s) of molecular weight larger than 200 kD; calpain and granulocyte or cysteine proteases do not seem to be this plasma substance(s).


Assuntos
Técnicas In Vitro , Perfusão/métodos , Plasma/química , Fator de von Willebrand/análise , Fator de von Willebrand/isolamento & purificação
3.
Rev. cuba. hematol. inmunol. hemoter ; 3(2): 241-50, mayo-ago. 1987. ilus, tab
Artigo em Espanhol | LILACS | ID: lil-53757

RESUMO

Se realizó la purificación del FVIII/FvW a partir de un concentrado comercial que había pasado la fecha de vencimiento para su uso terapéutico y se obtuvo un inmunógeno el cual se administró a un conejo con el objetivo de obtener un antisuero contra esa proteína. El antisuero obtenido se purificó posteriormente mediante una cromatografía de afinidad antigenoanticuerpo. Con la utilización de estos métodos hemos logrado obtener un antisuero el cual se puede utilizar para la determinación cuantitativa de FVIII/FvW sin necesidad de imponer este reactivo


Assuntos
Coelhos , Animais , Cromatografia de Afinidade , Fator VIII/isolamento & purificação , Soros Imunes/uso terapêutico , Imunoeletroforese/métodos , Fator de von Willebrand/isolamento & purificação
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA